| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Glutagen is a biopharmaceutical company based in Melbourne, Australia. Glutagen's primary focus is to provide clinically-relevant and scientific evidence-based medicines to support the health and wellbeing of individuals with gluten-related issues. Glutagen's holistic approach to personalised health involves the provision of the highest quality products, including the innovative enzyme supplement GluteGuard. Our flagship product, GluteGuard is the culmination of decades of Australian clinical research into enzyme supplementation in coeliac disease and related disorders. Glutagen's researchers hypothesised that intestinal gluten degradation by a specific and powerful enzyme could protect those suffering from gluten related disorders. This sparked the discovery that caricain, a natural enzyme found in the latex extracted from the Carica papaya fruit. Caricain facilitates the targeted and highly effective breakdown of gluten peptides, before these interact with the intestinal lining causing symptoms, inflammation and the associated autoimmune response in coeliac disease. |
| Category: | Hardware & devices, Health & biotech |
| URL: | https://glutagen.com/ |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2001 |
| Address: | 159 Dorcas Street, South Melbourne, VIC 3205, AU |
| State: | Victoria |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://linkedin.com/company/glutagen |
| Founders: |
No items found
|
| Awards won: | |
